nodes	percent_of_prediction	percent_of_DWPC	metapath
Mometasone—asthma—chronic obstructive pulmonary disease	0.33	1	CtDrD
Mometasone—Prednisone—chronic obstructive pulmonary disease	0.152	0.506	CrCtD
Mometasone—Prednisolone—chronic obstructive pulmonary disease	0.149	0.494	CrCtD
Mometasone—NR3C1—Prednisolone—chronic obstructive pulmonary disease	0.0411	0.395	CbGbCtD
Mometasone—NR3C1—Prednisone—chronic obstructive pulmonary disease	0.0388	0.373	CbGbCtD
Mometasone—CYP2C8—Montelukast—chronic obstructive pulmonary disease	0.0241	0.232	CbGbCtD
Mometasone—Prednicarbate—Prednisone—chronic obstructive pulmonary disease	0.00494	0.023	CrCrCtD
Mometasone—Testolactone—Prednisone—chronic obstructive pulmonary disease	0.00494	0.023	CrCrCtD
Mometasone—Prednicarbate—Prednisolone—chronic obstructive pulmonary disease	0.00482	0.0225	CrCrCtD
Mometasone—Testolactone—Prednisolone—chronic obstructive pulmonary disease	0.00482	0.0225	CrCrCtD
Mometasone—Clocortolone—Prednisolone—chronic obstructive pulmonary disease	0.00482	0.0225	CrCrCtD
Mometasone—Beclomethasone—Prednisolone—chronic obstructive pulmonary disease	0.00482	0.0225	CrCrCtD
Mometasone—Fluocortolone—Prednisone—chronic obstructive pulmonary disease	0.0048	0.0224	CrCrCtD
Mometasone—Fluocortolone—Prednisolone—chronic obstructive pulmonary disease	0.00469	0.0218	CrCrCtD
Mometasone—Alclometasone—Prednisone—chronic obstructive pulmonary disease	0.00467	0.0218	CrCrCtD
Mometasone—Alclometasone—Prednisolone—chronic obstructive pulmonary disease	0.00456	0.0212	CrCrCtD
Mometasone—Fluocinolone Acetonide—Prednisolone—chronic obstructive pulmonary disease	0.00456	0.0212	CrCrCtD
Mometasone—Budesonide—Prednisone—chronic obstructive pulmonary disease	0.00454	0.0212	CrCrCtD
Mometasone—Amcinonide—Prednisone—chronic obstructive pulmonary disease	0.00454	0.0212	CrCrCtD
Mometasone—Amcinonide—Prednisolone—chronic obstructive pulmonary disease	0.00443	0.0207	CrCrCtD
Mometasone—Fluoxymesterone—Prednisolone—chronic obstructive pulmonary disease	0.00443	0.0207	CrCrCtD
Mometasone—Budesonide—Prednisolone—chronic obstructive pulmonary disease	0.00443	0.0207	CrCrCtD
Mometasone—Diflorasone—Prednisone—chronic obstructive pulmonary disease	0.00442	0.0206	CrCrCtD
Mometasone—Fludrocortisone—Prednisone—chronic obstructive pulmonary disease	0.00442	0.0206	CrCrCtD
Mometasone—Desonide—Prednisone—chronic obstructive pulmonary disease	0.00442	0.0206	CrCrCtD
Mometasone—Clobetasol propionate—Prednisone—chronic obstructive pulmonary disease	0.00442	0.0206	CrCrCtD
Mometasone—Flunisolide—Prednisone—chronic obstructive pulmonary disease	0.00442	0.0206	CrCrCtD
Mometasone—Clobetasol propionate—Prednisolone—chronic obstructive pulmonary disease	0.00432	0.0201	CrCrCtD
Mometasone—Diflorasone—Prednisolone—chronic obstructive pulmonary disease	0.00432	0.0201	CrCrCtD
Mometasone—Prednisone—Prednisolone—chronic obstructive pulmonary disease	0.00432	0.0201	CrCrCtD
Mometasone—Desonide—Prednisolone—chronic obstructive pulmonary disease	0.00432	0.0201	CrCrCtD
Mometasone—Fludrocortisone—Prednisolone—chronic obstructive pulmonary disease	0.00432	0.0201	CrCrCtD
Mometasone—Flunisolide—Prednisolone—chronic obstructive pulmonary disease	0.00432	0.0201	CrCrCtD
Mometasone—Paramethasone—Prednisone—chronic obstructive pulmonary disease	0.00431	0.0201	CrCrCtD
Mometasone—Paramethasone—Prednisolone—chronic obstructive pulmonary disease	0.00421	0.0196	CrCrCtD
Mometasone—Desoximetasone—Prednisone—chronic obstructive pulmonary disease	0.00421	0.0196	CrCrCtD
Mometasone—Fluprednidene Acetate—Prednisone—chronic obstructive pulmonary disease	0.00411	0.0192	CrCrCtD
Mometasone—Loteprednol—Prednisone—chronic obstructive pulmonary disease	0.00411	0.0192	CrCrCtD
Mometasone—Fluorometholone—Prednisone—chronic obstructive pulmonary disease	0.00411	0.0192	CrCrCtD
Mometasone—Triamcinolone—Prednisone—chronic obstructive pulmonary disease	0.00411	0.0192	CrCrCtD
Mometasone—Desoximetasone—Prednisolone—chronic obstructive pulmonary disease	0.00411	0.0192	CrCrCtD
Mometasone—Dexamethasone—Prednisone—chronic obstructive pulmonary disease	0.00402	0.0187	CrCrCtD
Mometasone—Rimexolone—Prednisone—chronic obstructive pulmonary disease	0.00402	0.0187	CrCrCtD
Mometasone—Betamethasone—Prednisone—chronic obstructive pulmonary disease	0.00402	0.0187	CrCrCtD
Mometasone—Triamcinolone—Prednisolone—chronic obstructive pulmonary disease	0.00401	0.0187	CrCrCtD
Mometasone—Fluorometholone—Prednisolone—chronic obstructive pulmonary disease	0.00401	0.0187	CrCrCtD
Mometasone—Fluprednidene Acetate—Prednisolone—chronic obstructive pulmonary disease	0.00401	0.0187	CrCrCtD
Mometasone—Loteprednol—Prednisolone—chronic obstructive pulmonary disease	0.00401	0.0187	CrCrCtD
Mometasone—Rimexolone—Prednisolone—chronic obstructive pulmonary disease	0.00392	0.0183	CrCrCtD
Mometasone—Betamethasone—Prednisolone—chronic obstructive pulmonary disease	0.00392	0.0183	CrCrCtD
Mometasone—Dexamethasone—Prednisolone—chronic obstructive pulmonary disease	0.00392	0.0183	CrCrCtD
Mometasone—Methylprednisolone—Prednisone—chronic obstructive pulmonary disease	0.00384	0.0179	CrCrCtD
Mometasone—Prednisolone—Prednisone—chronic obstructive pulmonary disease	0.00376	0.0175	CrCrCtD
Mometasone—Methylprednisolone—Prednisolone—chronic obstructive pulmonary disease	0.00375	0.0175	CrCrCtD
Mometasone—Hydrocortisone—Prednisone—chronic obstructive pulmonary disease	0.00361	0.0168	CrCrCtD
Mometasone—Hydrocortisone—Prednisolone—chronic obstructive pulmonary disease	0.00352	0.0164	CrCrCtD
Mometasone—Glaucoma—Prednisolone—chronic obstructive pulmonary disease	0.000175	0.00364	CcSEcCtD
Mometasone—Infection—Roflumilast—chronic obstructive pulmonary disease	0.00017	0.00354	CcSEcCtD
Mometasone—Urinary tract infection—Tiotropium—chronic obstructive pulmonary disease	0.000164	0.00341	CcSEcCtD
Mometasone—Stinging—Prednisolone—chronic obstructive pulmonary disease	0.000163	0.00339	CcSEcCtD
Mometasone—Epistaxis—Tiotropium—chronic obstructive pulmonary disease	0.000159	0.00331	CcSEcCtD
Mometasone—Sinusitis—Tiotropium—chronic obstructive pulmonary disease	0.000158	0.00329	CcSEcCtD
Mometasone—Nasopharyngitis—Arformoterol—chronic obstructive pulmonary disease	0.000158	0.00329	CcSEcCtD
Mometasone—Nasopharyngitis—Formoterol—chronic obstructive pulmonary disease	0.000158	0.00329	CcSEcCtD
Mometasone—Musculoskeletal discomfort—Roflumilast—chronic obstructive pulmonary disease	0.000156	0.00324	CcSEcCtD
Mometasone—Nasopharyngitis—Montelukast—chronic obstructive pulmonary disease	0.000155	0.00322	CcSEcCtD
Mometasone—Influenza—Formoterol—chronic obstructive pulmonary disease	0.000153	0.00318	CcSEcCtD
Mometasone—Asthma—Formoterol—chronic obstructive pulmonary disease	0.000153	0.00318	CcSEcCtD
Mometasone—Influenza—Arformoterol—chronic obstructive pulmonary disease	0.000153	0.00318	CcSEcCtD
Mometasone—Asthma—Arformoterol—chronic obstructive pulmonary disease	0.000153	0.00318	CcSEcCtD
Mometasone—Rhinitis—Tiotropium—chronic obstructive pulmonary disease	0.000152	0.00316	CcSEcCtD
Mometasone—Dyspepsia—Roflumilast—chronic obstructive pulmonary disease	0.000151	0.00313	CcSEcCtD
Mometasone—Pharyngitis—Tiotropium—chronic obstructive pulmonary disease	0.00015	0.00313	CcSEcCtD
Mometasone—Bronchospasm—Arformoterol—chronic obstructive pulmonary disease	0.00015	0.00313	CcSEcCtD
Mometasone—Bronchospasm—Formoterol—chronic obstructive pulmonary disease	0.00015	0.00313	CcSEcCtD
Mometasone—Influenza—Montelukast—chronic obstructive pulmonary disease	0.00015	0.00311	CcSEcCtD
Mometasone—Asthma—Montelukast—chronic obstructive pulmonary disease	0.00015	0.00311	CcSEcCtD
Mometasone—Nasopharyngitis—Salbutamol—chronic obstructive pulmonary disease	0.000149	0.0031	CcSEcCtD
Mometasone—Decreased appetite—Roflumilast—chronic obstructive pulmonary disease	0.000149	0.0031	CcSEcCtD
Mometasone—Fatigue—Roflumilast—chronic obstructive pulmonary disease	0.000148	0.00307	CcSEcCtD
Mometasone—Bronchitis—Arformoterol—chronic obstructive pulmonary disease	0.000147	0.00306	CcSEcCtD
Mometasone—Bronchitis—Formoterol—chronic obstructive pulmonary disease	0.000147	0.00306	CcSEcCtD
Mometasone—Viral infection—Prednisolone—chronic obstructive pulmonary disease	0.000146	0.00304	CcSEcCtD
Mometasone—Asthma—Salbutamol—chronic obstructive pulmonary disease	0.000144	0.003	CcSEcCtD
Mometasone—Influenza—Salbutamol—chronic obstructive pulmonary disease	0.000144	0.003	CcSEcCtD
Mometasone—Bronchitis—Montelukast—chronic obstructive pulmonary disease	0.000144	0.00299	CcSEcCtD
Mometasone—Upper respiratory tract infection—Formoterol—chronic obstructive pulmonary disease	0.000142	0.00295	CcSEcCtD
Mometasone—Upper respiratory tract infection—Arformoterol—chronic obstructive pulmonary disease	0.000142	0.00295	CcSEcCtD
Mometasone—Bronchospasm—Salbutamol—chronic obstructive pulmonary disease	0.000142	0.00295	CcSEcCtD
Mometasone—Gastrointestinal pain—Roflumilast—chronic obstructive pulmonary disease	0.00014	0.00291	CcSEcCtD
Mometasone—Upper respiratory tract infection—Montelukast—chronic obstructive pulmonary disease	0.000139	0.00289	CcSEcCtD
Mometasone—Bronchitis—Salbutamol—chronic obstructive pulmonary disease	0.000139	0.00289	CcSEcCtD
Mometasone—Immune system disorder—Tiotropium—chronic obstructive pulmonary disease	0.000137	0.00285	CcSEcCtD
Mometasone—Mediastinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000137	0.00284	CcSEcCtD
Mometasone—Abdominal pain—Roflumilast—chronic obstructive pulmonary disease	0.000135	0.00281	CcSEcCtD
Mometasone—Upper respiratory tract infection—Salbutamol—chronic obstructive pulmonary disease	0.000134	0.00279	CcSEcCtD
Mometasone—Conjunctivitis—Formoterol—chronic obstructive pulmonary disease	0.000132	0.00275	CcSEcCtD
Mometasone—Conjunctivitis—Arformoterol—chronic obstructive pulmonary disease	0.000132	0.00275	CcSEcCtD
Mometasone—Urinary tract infection—Arformoterol—chronic obstructive pulmonary disease	0.000132	0.00275	CcSEcCtD
Mometasone—Urinary tract infection—Formoterol—chronic obstructive pulmonary disease	0.000132	0.00275	CcSEcCtD
Mometasone—Conjunctivitis—Montelukast—chronic obstructive pulmonary disease	0.00013	0.0027	CcSEcCtD
Mometasone—Sinusitis—Arformoterol—chronic obstructive pulmonary disease	0.000128	0.00266	CcSEcCtD
Mometasone—Sinusitis—Formoterol—chronic obstructive pulmonary disease	0.000128	0.00266	CcSEcCtD
Mometasone—Back pain—Tiotropium—chronic obstructive pulmonary disease	0.000128	0.00265	CcSEcCtD
Mometasone—Glaucoma—Prednisone—chronic obstructive pulmonary disease	0.000127	0.00265	CcSEcCtD
Mometasone—Epistaxis—Montelukast—chronic obstructive pulmonary disease	0.000126	0.00262	CcSEcCtD
Mometasone—Sinusitis—Montelukast—chronic obstructive pulmonary disease	0.000125	0.0026	CcSEcCtD
Mometasone—Urinary tract infection—Salbutamol—chronic obstructive pulmonary disease	0.000125	0.0026	CcSEcCtD
Mometasone—Conjunctivitis—Salbutamol—chronic obstructive pulmonary disease	0.000125	0.0026	CcSEcCtD
Mometasone—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.000123	0.00255	CcSEcCtD
Mometasone—Rhinitis—Arformoterol—chronic obstructive pulmonary disease	0.000123	0.00255	CcSEcCtD
Mometasone—Rhinitis—Formoterol—chronic obstructive pulmonary disease	0.000123	0.00255	CcSEcCtD
Mometasone—Pharyngitis—Formoterol—chronic obstructive pulmonary disease	0.000121	0.00252	CcSEcCtD
Mometasone—Pharyngitis—Arformoterol—chronic obstructive pulmonary disease	0.000121	0.00252	CcSEcCtD
Mometasone—Epistaxis—Salbutamol—chronic obstructive pulmonary disease	0.000121	0.00252	CcSEcCtD
Mometasone—Sinusitis—Salbutamol—chronic obstructive pulmonary disease	0.000121	0.00251	CcSEcCtD
Mometasone—Angioedema—Tiotropium—chronic obstructive pulmonary disease	0.000121	0.00251	CcSEcCtD
Mometasone—Rhinitis—Montelukast—chronic obstructive pulmonary disease	0.00012	0.0025	CcSEcCtD
Mometasone—Pharyngitis—Montelukast—chronic obstructive pulmonary disease	0.000119	0.00247	CcSEcCtD
Mometasone—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.000117	0.00244	CcSEcCtD
Mometasone—Rhinitis—Salbutamol—chronic obstructive pulmonary disease	0.000116	0.00241	CcSEcCtD
Mometasone—Endocrine disorder—Prednisone—chronic obstructive pulmonary disease	0.000116	0.0024	CcSEcCtD
Mometasone—Cough—Tiotropium—chronic obstructive pulmonary disease	0.000115	0.00239	CcSEcCtD
Mometasone—Pharyngitis—Salbutamol—chronic obstructive pulmonary disease	0.000115	0.00238	CcSEcCtD
Mometasone—Anaphylactic shock—Aminophylline—chronic obstructive pulmonary disease	0.000114	0.00237	CcSEcCtD
Mometasone—Infection—Aminophylline—chronic obstructive pulmonary disease	0.000113	0.00236	CcSEcCtD
Mometasone—Chest pain—Tiotropium—chronic obstructive pulmonary disease	0.000112	0.00234	CcSEcCtD
Mometasone—Myalgia—Tiotropium—chronic obstructive pulmonary disease	0.000112	0.00234	CcSEcCtD
Mometasone—Arthralgia—Tiotropium—chronic obstructive pulmonary disease	0.000112	0.00234	CcSEcCtD
Mometasone—Immune system disorder—Arformoterol—chronic obstructive pulmonary disease	0.00011	0.0023	CcSEcCtD
Mometasone—Immune system disorder—Formoterol—chronic obstructive pulmonary disease	0.00011	0.0023	CcSEcCtD
Mometasone—Mediastinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.00011	0.00229	CcSEcCtD
Mometasone—Mediastinal disorder—Formoterol—chronic obstructive pulmonary disease	0.00011	0.00229	CcSEcCtD
Mometasone—Contusion—Prednisone—chronic obstructive pulmonary disease	0.00011	0.00228	CcSEcCtD
Mometasone—Dry mouth—Tiotropium—chronic obstructive pulmonary disease	0.00011	0.00228	CcSEcCtD
Mometasone—CYP2C8—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A2—chronic obstructive pulmonary disease	0.00011	0.0656	CbGpPWpGaD
Mometasone—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.000109	0.00226	CcSEcCtD
Mometasone—Anorexia—Aminophylline—chronic obstructive pulmonary disease	0.000109	0.00226	CcSEcCtD
Mometasone—Immune system disorder—Montelukast—chronic obstructive pulmonary disease	0.000108	0.00225	CcSEcCtD
Mometasone—Mediastinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000108	0.00225	CcSEcCtD
Mometasone—Rash—Roflumilast—chronic obstructive pulmonary disease	0.000108	0.00225	CcSEcCtD
Mometasone—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.000108	0.00224	CcSEcCtD
Mometasone—Headache—Roflumilast—chronic obstructive pulmonary disease	0.000107	0.00223	CcSEcCtD
Mometasone—Infection—Tiotropium—chronic obstructive pulmonary disease	0.000107	0.00222	CcSEcCtD
Mometasone—Viral infection—Prednisone—chronic obstructive pulmonary disease	0.000106	0.00221	CcSEcCtD
Mometasone—Immune system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000104	0.00217	CcSEcCtD
Mometasone—Injury—Prednisolone—chronic obstructive pulmonary disease	0.000104	0.00217	CcSEcCtD
Mometasone—Mediastinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000104	0.00216	CcSEcCtD
Mometasone—Back pain—Formoterol—chronic obstructive pulmonary disease	0.000103	0.00214	CcSEcCtD
Mometasone—Back pain—Arformoterol—chronic obstructive pulmonary disease	0.000103	0.00214	CcSEcCtD
Mometasone—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000102	0.00212	CcSEcCtD
Mometasone—CYP2C8—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—chronic obstructive pulmonary disease	0.000102	0.0609	CbGpPWpGaD
Mometasone—Ulcer—Prednisone—chronic obstructive pulmonary disease	0.000101	0.00211	CcSEcCtD
Mometasone—Cataract—Prednisone—chronic obstructive pulmonary disease	0.000101	0.00209	CcSEcCtD
Mometasone—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.000101	0.00209	CcSEcCtD
Mometasone—CYP2C8—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A2—chronic obstructive pulmonary disease	9.97e-05	0.0597	CbGpPWpGaD
Mometasone—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	9.93e-05	0.00206	CcSEcCtD
Mometasone—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	9.81e-05	0.00204	CcSEcCtD
Mometasone—Angioedema—Arformoterol—chronic obstructive pulmonary disease	9.73e-05	0.00202	CcSEcCtD
Mometasone—Angioedema—Formoterol—chronic obstructive pulmonary disease	9.73e-05	0.00202	CcSEcCtD
Mometasone—Back pain—Salbutamol—chronic obstructive pulmonary disease	9.73e-05	0.00202	CcSEcCtD
Mometasone—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	9.67e-05	0.00201	CcSEcCtD
Mometasone—Angioedema—Montelukast—chronic obstructive pulmonary disease	9.53e-05	0.00198	CcSEcCtD
Mometasone—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	9.48e-05	0.00197	CcSEcCtD
Mometasone—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	9.34e-05	0.00194	CcSEcCtD
Mometasone—Cough—Arformoterol—chronic obstructive pulmonary disease	9.29e-05	0.00193	CcSEcCtD
Mometasone—Cough—Formoterol—chronic obstructive pulmonary disease	9.29e-05	0.00193	CcSEcCtD
Mometasone—Clobetasol propionate—CYP1A1—chronic obstructive pulmonary disease	9.19e-05	0.282	CrCbGaD
Mometasone—Angioedema—Salbutamol—chronic obstructive pulmonary disease	9.19e-05	0.00191	CcSEcCtD
Mometasone—Cough—Montelukast—chronic obstructive pulmonary disease	9.1e-05	0.00189	CcSEcCtD
Mometasone—Arthralgia—Formoterol—chronic obstructive pulmonary disease	9.07e-05	0.00189	CcSEcCtD
Mometasone—Myalgia—Formoterol—chronic obstructive pulmonary disease	9.07e-05	0.00189	CcSEcCtD
Mometasone—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	9.07e-05	0.00189	CcSEcCtD
Mometasone—Chest pain—Formoterol—chronic obstructive pulmonary disease	9.07e-05	0.00189	CcSEcCtD
Mometasone—Chest pain—Arformoterol—chronic obstructive pulmonary disease	9.07e-05	0.00189	CcSEcCtD
Mometasone—Myalgia—Arformoterol—chronic obstructive pulmonary disease	9.07e-05	0.00189	CcSEcCtD
Mometasone—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	9.03e-05	0.00188	CcSEcCtD
Mometasone—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	9.03e-05	0.00188	CcSEcCtD
Mometasone—Myalgia—Montelukast—chronic obstructive pulmonary disease	8.88e-05	0.00185	CcSEcCtD
Mometasone—Arthralgia—Montelukast—chronic obstructive pulmonary disease	8.88e-05	0.00185	CcSEcCtD
Mometasone—Dry mouth—Formoterol—chronic obstructive pulmonary disease	8.87e-05	0.00184	CcSEcCtD
Mometasone—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	8.87e-05	0.00184	CcSEcCtD
Mometasone—Clobetasol propionate—CYP1A2—chronic obstructive pulmonary disease	8.87e-05	0.272	CrCbGaD
Mometasone—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	8.81e-05	0.00183	CcSEcCtD
Mometasone—Cough—Salbutamol—chronic obstructive pulmonary disease	8.77e-05	0.00182	CcSEcCtD
Mometasone—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	8.69e-05	0.00181	CcSEcCtD
Mometasone—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	8.69e-05	0.00181	CcSEcCtD
Mometasone—Infection—Formoterol—chronic obstructive pulmonary disease	8.63e-05	0.0018	CcSEcCtD
Mometasone—Infection—Arformoterol—chronic obstructive pulmonary disease	8.63e-05	0.0018	CcSEcCtD
Mometasone—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	8.56e-05	0.00178	CcSEcCtD
Mometasone—Chest pain—Salbutamol—chronic obstructive pulmonary disease	8.56e-05	0.00178	CcSEcCtD
Mometasone—Myalgia—Salbutamol—chronic obstructive pulmonary disease	8.56e-05	0.00178	CcSEcCtD
Mometasone—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	8.51e-05	0.00177	CcSEcCtD
Mometasone—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	8.51e-05	0.00177	CcSEcCtD
Mometasone—Infection—Montelukast—chronic obstructive pulmonary disease	8.46e-05	0.00176	CcSEcCtD
Mometasone—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	8.37e-05	0.00174	CcSEcCtD
Mometasone—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	8.21e-05	0.00171	CcSEcCtD
Mometasone—Infection—Salbutamol—chronic obstructive pulmonary disease	8.15e-05	0.0017	CcSEcCtD
Mometasone—Pruritus—Aminophylline—chronic obstructive pulmonary disease	8.08e-05	0.00168	CcSEcCtD
Mometasone—NR3C1—Transcription factor regulation in adipogenesis—ADIPOQ—chronic obstructive pulmonary disease	8.03e-05	0.0481	CbGpPWpGaD
Mometasone—CYP2C8—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—chronic obstructive pulmonary disease	7.96e-05	0.0477	CbGpPWpGaD
Mometasone—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	7.92e-05	0.00165	CcSEcCtD
Mometasone—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	7.92e-05	0.00165	CcSEcCtD
Mometasone—Anorexia—Salbutamol—chronic obstructive pulmonary disease	7.82e-05	0.00163	CcSEcCtD
Mometasone—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	7.81e-05	0.00162	CcSEcCtD
Mometasone—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	7.76e-05	0.00161	CcSEcCtD
Mometasone—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	7.75e-05	0.00161	CcSEcCtD
Mometasone—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	7.75e-05	0.00161	CcSEcCtD
Mometasone—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	7.65e-05	0.00159	CcSEcCtD
Mometasone—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	7.65e-05	0.00159	CcSEcCtD
Mometasone—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	7.64e-05	0.00159	CcSEcCtD
Mometasone—Pruritus—Tiotropium—chronic obstructive pulmonary disease	7.62e-05	0.00158	CcSEcCtD
Mometasone—Injury—Prednisone—chronic obstructive pulmonary disease	7.57e-05	0.00157	CcSEcCtD
Mometasone—Dexamethasone—NOS2—chronic obstructive pulmonary disease	7.5e-05	0.23	CrCbGaD
Mometasone—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	7.49e-05	0.00156	CcSEcCtD
Mometasone—Fatigue—Formoterol—chronic obstructive pulmonary disease	7.49e-05	0.00156	CcSEcCtD
Mometasone—Fatigue—Arformoterol—chronic obstructive pulmonary disease	7.49e-05	0.00156	CcSEcCtD
Mometasone—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	7.48e-05	0.00155	CcSEcCtD
Mometasone—Pain—Formoterol—chronic obstructive pulmonary disease	7.43e-05	0.00155	CcSEcCtD
Mometasone—Pain—Arformoterol—chronic obstructive pulmonary disease	7.43e-05	0.00155	CcSEcCtD
Mometasone—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	7.37e-05	0.00153	CcSEcCtD
Mometasone—Fatigue—Montelukast—chronic obstructive pulmonary disease	7.34e-05	0.00153	CcSEcCtD
Mometasone—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	7.32e-05	0.00152	CcSEcCtD
Mometasone—Pain—Montelukast—chronic obstructive pulmonary disease	7.28e-05	0.00151	CcSEcCtD
Mometasone—Vomiting—Aminophylline—chronic obstructive pulmonary disease	7.26e-05	0.00151	CcSEcCtD
Mometasone—CYP2C8—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—chronic obstructive pulmonary disease	7.24e-05	0.0434	CbGpPWpGaD
Mometasone—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	7.22e-05	0.0015	CcSEcCtD
Mometasone—Rash—Aminophylline—chronic obstructive pulmonary disease	7.2e-05	0.0015	CcSEcCtD
Mometasone—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	7.19e-05	0.0015	CcSEcCtD
Mometasone—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	7.17e-05	0.00149	CcSEcCtD
Mometasone—Headache—Aminophylline—chronic obstructive pulmonary disease	7.15e-05	0.00149	CcSEcCtD
Mometasone—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	7.13e-05	0.00148	CcSEcCtD
Mometasone—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	7.11e-05	0.00148	CcSEcCtD
Mometasone—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	7.11e-05	0.00148	CcSEcCtD
Mometasone—Fatigue—Salbutamol—chronic obstructive pulmonary disease	7.08e-05	0.00147	CcSEcCtD
Mometasone—Pain—Salbutamol—chronic obstructive pulmonary disease	7.02e-05	0.00146	CcSEcCtD
Mometasone—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	6.96e-05	0.00145	CcSEcCtD
Mometasone—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	6.87e-05	0.00143	CcSEcCtD
Mometasone—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	6.87e-05	0.00143	CcSEcCtD
Mometasone—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	6.87e-05	0.00143	CcSEcCtD
Mometasone—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	6.87e-05	0.00143	CcSEcCtD
Mometasone—Vomiting—Tiotropium—chronic obstructive pulmonary disease	6.85e-05	0.00142	CcSEcCtD
Mometasone—Rash—Tiotropium—chronic obstructive pulmonary disease	6.79e-05	0.00141	CcSEcCtD
Mometasone—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	6.78e-05	0.00141	CcSEcCtD
Mometasone—Nausea—Aminophylline—chronic obstructive pulmonary disease	6.78e-05	0.00141	CcSEcCtD
Mometasone—Headache—Tiotropium—chronic obstructive pulmonary disease	6.75e-05	0.0014	CcSEcCtD
Mometasone—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	6.73e-05	0.0014	CcSEcCtD
Mometasone—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	6.73e-05	0.0014	CcSEcCtD
Mometasone—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	6.71e-05	0.0014	CcSEcCtD
Mometasone—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	6.49e-05	0.00135	CcSEcCtD
Mometasone—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	6.49e-05	0.00135	CcSEcCtD
Mometasone—Nausea—Tiotropium—chronic obstructive pulmonary disease	6.4e-05	0.00133	CcSEcCtD
Mometasone—Asthenia—Arformoterol—chronic obstructive pulmonary disease	6.24e-05	0.0013	CcSEcCtD
Mometasone—Asthenia—Formoterol—chronic obstructive pulmonary disease	6.24e-05	0.0013	CcSEcCtD
Mometasone—Pruritus—Formoterol—chronic obstructive pulmonary disease	6.15e-05	0.00128	CcSEcCtD
Mometasone—Pruritus—Arformoterol—chronic obstructive pulmonary disease	6.15e-05	0.00128	CcSEcCtD
Mometasone—Asthenia—Montelukast—chronic obstructive pulmonary disease	6.11e-05	0.00127	CcSEcCtD
Mometasone—Pruritus—Montelukast—chronic obstructive pulmonary disease	6.02e-05	0.00125	CcSEcCtD
Mometasone—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	5.95e-05	0.00124	CcSEcCtD
Mometasone—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	5.95e-05	0.00124	CcSEcCtD
Mometasone—Asthenia—Salbutamol—chronic obstructive pulmonary disease	5.89e-05	0.00122	CcSEcCtD
Mometasone—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	5.82e-05	0.00121	CcSEcCtD
Mometasone—Pruritus—Salbutamol—chronic obstructive pulmonary disease	5.81e-05	0.00121	CcSEcCtD
Mometasone—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	5.62e-05	0.00117	CcSEcCtD
Mometasone—Vomiting—Arformoterol—chronic obstructive pulmonary disease	5.53e-05	0.00115	CcSEcCtD
Mometasone—Vomiting—Formoterol—chronic obstructive pulmonary disease	5.53e-05	0.00115	CcSEcCtD
Mometasone—Rash—Arformoterol—chronic obstructive pulmonary disease	5.48e-05	0.00114	CcSEcCtD
Mometasone—Rash—Formoterol—chronic obstructive pulmonary disease	5.48e-05	0.00114	CcSEcCtD
Mometasone—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	5.47e-05	0.00114	CcSEcCtD
Mometasone—Dermatitis—Formoterol—chronic obstructive pulmonary disease	5.47e-05	0.00114	CcSEcCtD
Mometasone—Headache—Formoterol—chronic obstructive pulmonary disease	5.44e-05	0.00113	CcSEcCtD
Mometasone—Headache—Arformoterol—chronic obstructive pulmonary disease	5.44e-05	0.00113	CcSEcCtD
Mometasone—Vomiting—Montelukast—chronic obstructive pulmonary disease	5.41e-05	0.00113	CcSEcCtD
Mometasone—Rash—Montelukast—chronic obstructive pulmonary disease	5.37e-05	0.00112	CcSEcCtD
Mometasone—Dermatitis—Montelukast—chronic obstructive pulmonary disease	5.36e-05	0.00112	CcSEcCtD
Mometasone—Headache—Montelukast—chronic obstructive pulmonary disease	5.33e-05	0.00111	CcSEcCtD
Mometasone—Angioedema—Prednisolone—chronic obstructive pulmonary disease	5.27e-05	0.0011	CcSEcCtD
Mometasone—CYP2C8—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	5.26e-05	0.0315	CbGpPWpGaD
Mometasone—Vomiting—Salbutamol—chronic obstructive pulmonary disease	5.22e-05	0.00109	CcSEcCtD
Mometasone—Rash—Salbutamol—chronic obstructive pulmonary disease	5.17e-05	0.00108	CcSEcCtD
Mometasone—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	5.17e-05	0.00107	CcSEcCtD
Mometasone—Nausea—Arformoterol—chronic obstructive pulmonary disease	5.16e-05	0.00107	CcSEcCtD
Mometasone—Nausea—Formoterol—chronic obstructive pulmonary disease	5.16e-05	0.00107	CcSEcCtD
Mometasone—Headache—Salbutamol—chronic obstructive pulmonary disease	5.14e-05	0.00107	CcSEcCtD
Mometasone—CYP2C8—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	5.06e-05	0.0303	CbGpPWpGaD
Mometasone—Nausea—Montelukast—chronic obstructive pulmonary disease	5.06e-05	0.00105	CcSEcCtD
Mometasone—NR3C1—Transcription factor regulation in adipogenesis—LEP—chronic obstructive pulmonary disease	4.99e-05	0.0299	CbGpPWpGaD
Mometasone—Nausea—Salbutamol—chronic obstructive pulmonary disease	4.87e-05	0.00101	CcSEcCtD
Mometasone—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	4.71e-05	0.000979	CcSEcCtD
Mometasone—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	4.35e-05	0.000904	CcSEcCtD
Mometasone—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	4.23e-05	0.000879	CcSEcCtD
Mometasone—Pain—Prednisolone—chronic obstructive pulmonary disease	4.03e-05	0.000837	CcSEcCtD
Mometasone—Angioedema—Prednisone—chronic obstructive pulmonary disease	3.83e-05	0.000796	CcSEcCtD
Mometasone—CYP2C8—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	3.82e-05	0.0229	CbGpPWpGaD
Mometasone—CYP2C8—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	3.68e-05	0.022	CbGpPWpGaD
Mometasone—Prednisone—ALB—chronic obstructive pulmonary disease	3.65e-05	0.112	CrCbGaD
Mometasone—Myalgia—Prednisone—chronic obstructive pulmonary disease	3.57e-05	0.000742	CcSEcCtD
Mometasone—Arthralgia—Prednisone—chronic obstructive pulmonary disease	3.57e-05	0.000742	CcSEcCtD
Mometasone—Dexamethasone—CYP1A1—chronic obstructive pulmonary disease	3.44e-05	0.105	CrCbGaD
Mometasone—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	3.42e-05	0.000711	CcSEcCtD
Mometasone—Infection—Prednisone—chronic obstructive pulmonary disease	3.4e-05	0.000707	CcSEcCtD
Mometasone—NR3C1—Glucocorticoid receptor regulatory network—IL13—chronic obstructive pulmonary disease	3.38e-05	0.0202	CbGpPWpGaD
Mometasone—Anorexia—Prednisone—chronic obstructive pulmonary disease	3.26e-05	0.000678	CcSEcCtD
Mometasone—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	3.12e-05	0.000648	CcSEcCtD
Mometasone—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	3.07e-05	0.000639	CcSEcCtD
Mometasone—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	3.01e-05	0.000626	CcSEcCtD
Mometasone—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	2.97e-05	0.000618	CcSEcCtD
Mometasone—Rash—Prednisolone—chronic obstructive pulmonary disease	2.97e-05	0.000617	CcSEcCtD
Mometasone—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	2.97e-05	0.000617	CcSEcCtD
Mometasone—Fatigue—Prednisone—chronic obstructive pulmonary disease	2.95e-05	0.000613	CcSEcCtD
Mometasone—Headache—Prednisolone—chronic obstructive pulmonary disease	2.95e-05	0.000613	CcSEcCtD
Mometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—HDAC2—chronic obstructive pulmonary disease	2.82e-05	0.0169	CbGpPWpGaD
Mometasone—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	2.8e-05	0.000582	CcSEcCtD
Mometasone—Nausea—Prednisolone—chronic obstructive pulmonary disease	2.8e-05	0.000581	CcSEcCtD
Mometasone—NR3C1—Glucocorticoid receptor regulatory network—HDAC2—chronic obstructive pulmonary disease	2.79e-05	0.0167	CbGpPWpGaD
Mometasone—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	2.7e-05	0.000562	CcSEcCtD
Mometasone—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	2.7e-05	0.000562	CcSEcCtD
Mometasone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—SERPINE1—chronic obstructive pulmonary disease	2.58e-05	0.0155	CbGpPWpGaD
Mometasone—CYP2C8—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	2.53e-05	0.0151	CbGpPWpGaD
Mometasone—Asthenia—Prednisone—chronic obstructive pulmonary disease	2.45e-05	0.00051	CcSEcCtD
Mometasone—NR3C1—AP-1 transcription factor network—EDN1—chronic obstructive pulmonary disease	2.43e-05	0.0145	CbGpPWpGaD
Mometasone—Pruritus—Prednisone—chronic obstructive pulmonary disease	2.42e-05	0.000503	CcSEcCtD
Mometasone—NR3C1—AP-1 transcription factor network—IL10—chronic obstructive pulmonary disease	2.4e-05	0.0144	CbGpPWpGaD
Mometasone—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	2.34e-05	0.000487	CcSEcCtD
Mometasone—NR3C1—Transcription factor regulation in adipogenesis—TNF—chronic obstructive pulmonary disease	2.31e-05	0.0138	CbGpPWpGaD
Mometasone—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—chronic obstructive pulmonary disease	2.24e-05	0.0134	CbGpPWpGaD
Mometasone—CYP2C8—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	2.23e-05	0.0134	CbGpPWpGaD
Mometasone—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	2.18e-05	0.0131	CbGpPWpGaD
Mometasone—Vomiting—Prednisone—chronic obstructive pulmonary disease	2.17e-05	0.000452	CcSEcCtD
Mometasone—Rash—Prednisone—chronic obstructive pulmonary disease	2.16e-05	0.000448	CcSEcCtD
Mometasone—CYP2C8—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	2.16e-05	0.0129	CbGpPWpGaD
Mometasone—Dermatitis—Prednisone—chronic obstructive pulmonary disease	2.15e-05	0.000448	CcSEcCtD
Mometasone—Headache—Prednisone—chronic obstructive pulmonary disease	2.14e-05	0.000446	CcSEcCtD
Mometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—chronic obstructive pulmonary disease	2.14e-05	0.0128	CbGpPWpGaD
Mometasone—NR3C1—AP-1 transcription factor network—MMP1—chronic obstructive pulmonary disease	2.04e-05	0.0122	CbGpPWpGaD
Mometasone—Nausea—Prednisone—chronic obstructive pulmonary disease	2.03e-05	0.000422	CcSEcCtD
Mometasone—NR3C1—SIDS Susceptibility Pathways—IL13—chronic obstructive pulmonary disease	2.02e-05	0.0121	CbGpPWpGaD
Mometasone—NR3C1—AP-1 transcription factor network—PLAU—chronic obstructive pulmonary disease	2e-05	0.012	CbGpPWpGaD
Mometasone—NR3C1—Adipogenesis—ADIPOQ—chronic obstructive pulmonary disease	1.94e-05	0.0116	CbGpPWpGaD
Mometasone—NR3C1—Circadian Clock—SERPINE1—chronic obstructive pulmonary disease	1.88e-05	0.0113	CbGpPWpGaD
Mometasone—NR3C1—Transcription factor regulation in adipogenesis—IL6—chronic obstructive pulmonary disease	1.86e-05	0.0111	CbGpPWpGaD
Mometasone—CYP2C8—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	1.84e-05	0.011	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—SLC6A4—chronic obstructive pulmonary disease	1.82e-05	0.0109	CbGpPWpGaD
Mometasone—NR3C1—Glucocorticoid receptor regulatory network—MMP1—chronic obstructive pulmonary disease	1.8e-05	0.0108	CbGpPWpGaD
Mometasone—CYP2C8—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	1.77e-05	0.0106	CbGpPWpGaD
Mometasone—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	1.59e-05	0.00951	CbGpPWpGaD
Mometasone—CYP2C8—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	1.57e-05	0.00938	CbGpPWpGaD
Mometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—SERPINE1—chronic obstructive pulmonary disease	1.38e-05	0.00826	CbGpPWpGaD
Mometasone—NR3C1—AP-1 transcription factor network—CXCL8—chronic obstructive pulmonary disease	1.31e-05	0.00786	CbGpPWpGaD
Mometasone—CYP2C8—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	1.29e-05	0.00771	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—IL10—chronic obstructive pulmonary disease	1.26e-05	0.00757	CbGpPWpGaD
Mometasone—NR3C1—Adipogenesis—LEP—chronic obstructive pulmonary disease	1.2e-05	0.00721	CbGpPWpGaD
Mometasone—NR3C1—AP-1 transcription factor network—MMP9—chronic obstructive pulmonary disease	1.19e-05	0.00711	CbGpPWpGaD
Mometasone—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—chronic obstructive pulmonary disease	1.16e-05	0.00693	CbGpPWpGaD
Mometasone—CYP2C8—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	1.13e-05	0.00678	CbGpPWpGaD
Mometasone—CYP2C8—Biological oxidations—GCLC—chronic obstructive pulmonary disease	1.12e-05	0.0067	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	1.12e-05	0.0067	CbGpPWpGaD
Mometasone—NR3C1—Endoderm Differentiation—TGFB1—chronic obstructive pulmonary disease	1e-05	0.006	CbGpPWpGaD
Mometasone—NR3C1—AP-1 transcription factor network—TGFB1—chronic obstructive pulmonary disease	9.78e-06	0.00586	CbGpPWpGaD
Mometasone—NR3C1—Adipogenesis—SERPINE1—chronic obstructive pulmonary disease	9.44e-06	0.00566	CbGpPWpGaD
Mometasone—CYP2C8—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	9.41e-06	0.00563	CbGpPWpGaD
Mometasone—CYP2C8—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	9.28e-06	0.00556	CbGpPWpGaD
Mometasone—NR3C1—AP-1 transcription factor network—TP53—chronic obstructive pulmonary disease	8.05e-06	0.00482	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	7.96e-06	0.00477	CbGpPWpGaD
Mometasone—CYP2C8—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	7.85e-06	0.0047	CbGpPWpGaD
Mometasone—CYP2C8—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	7.74e-06	0.00464	CbGpPWpGaD
Mometasone—NR3C1—Generic Transcription Pathway—CTGF—chronic obstructive pulmonary disease	7.56e-06	0.00453	CbGpPWpGaD
Mometasone—NR3C1—AP-1 transcription factor network—IL6—chronic obstructive pulmonary disease	7.37e-06	0.00442	CbGpPWpGaD
Mometasone—CYP2C8—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	7.21e-06	0.00432	CbGpPWpGaD
Mometasone—CYP2C8—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	7.11e-06	0.00426	CbGpPWpGaD
Mometasone—NR3C1—Glucocorticoid receptor regulatory network—TP53—chronic obstructive pulmonary disease	7.1e-06	0.00425	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	6.91e-06	0.00414	CbGpPWpGaD
Mometasone—CYP2C8—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	6.84e-06	0.00409	CbGpPWpGaD
Mometasone—CYP2C8—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	6.74e-06	0.00404	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	6.63e-06	0.00397	CbGpPWpGaD
Mometasone—NR3C1—Glucocorticoid receptor regulatory network—IL6—chronic obstructive pulmonary disease	6.5e-06	0.00389	CbGpPWpGaD
Mometasone—NR3C1—Adipogenesis—TGFB1—chronic obstructive pulmonary disease	5.96e-06	0.00357	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	5.61e-06	0.00336	CbGpPWpGaD
Mometasone—NR3C1—Adipogenesis—TNF—chronic obstructive pulmonary disease	5.57e-06	0.00333	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—APIP—chronic obstructive pulmonary disease	5.5e-06	0.00329	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	4.81e-06	0.00288	CbGpPWpGaD
Mometasone—NR3C1—Adipogenesis—IL6—chronic obstructive pulmonary disease	4.49e-06	0.00269	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	3.92e-06	0.00235	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	3.88e-06	0.00233	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.64e-06	0.00218	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—CTGF—chronic obstructive pulmonary disease	3.64e-06	0.00218	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	3.61e-06	0.00216	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—GC—chronic obstructive pulmonary disease	3.54e-06	0.00212	CbGpPWpGaD
Mometasone—NR3C1—Generic Transcription Pathway—SERPINE1—chronic obstructive pulmonary disease	3.45e-06	0.00207	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—HDAC2—chronic obstructive pulmonary disease	3.39e-06	0.00203	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.29e-06	0.00197	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.62e-06	0.00157	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.94e-06	0.00116	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—GCLC—chronic obstructive pulmonary disease	1.91e-06	0.00115	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.78e-06	0.00107	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—CTGF—chronic obstructive pulmonary disease	1.75e-06	0.00105	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	1.66e-06	0.000994	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.61e-06	0.000964	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.34e-06	0.000804	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.32e-06	0.000793	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.23e-06	0.000739	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.17e-06	0.0007	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—ALB—chronic obstructive pulmonary disease	7.95e-07	0.000476	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—NOS3—chronic obstructive pulmonary disease	7.6e-07	0.000455	CbGpPWpGaD
